“…Thus, we cannot exclude the possibility that the anesthetic used in the present study could have masked additional between-genotype differences because of NMDAR inhibition by Ketamine. Nevertheless, we believe that the observed genotype differences are valid because high-amplitude cerebrovascular responses were observed under Ketamine/Xylazine anesthesia (Wey et al, 2010;Kim and Jeong, 2013), and the overall magnitude of hemodynamic responses reported here (3-4% change) was similar to previous studies performed with alpha-chloralose (Dubeau et al, 2011). More importantly, the application of NMDAR and AMPAR antagonists blocks the hemodynamic response to somatosensory stimulation under Ketamine/Xylazine anesthesia (Scott and Murphy, 2012), which supports that glutamatergic transmission is preserved under such anesthetic conditions and that our findings of altered cerebrovascular parameters in Nlgn1 KO mice could be linked to modifications in glutamate receptor functions.…”